Similar to GHB treatment, siRNA-mediated ALDH5A1 downregulation in TG1 (adult GBM) and TP54 (infant DIPG) cells decreased Nanog nuclear localization (Fig. 3e). The gene discussed is NANOG; the disease is glioblastoma.